HopeStage
Back to all studies
CompletedNCT01986296

ExAblate Focused Ultrasound for Treatment-Resistant OCD

About this title

ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder

Read the official source — NCT01986296
Device studyAges 18–65South Korea
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2013
Recruitment status
Completed
Enrollment listed in the registry
25
Sponsor
InSightec
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
South Korea
Age range
From 18 Years to 65 Years
Official registry ID
NCT01986296
Official title
Show the full official title

A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound Treatment of Medication-Refractory OCD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Seoul

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is InSightec.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies